1 |
Shimada S, Yang C, Kurth T, Cowley AW Jr. Divergent roles of angiotensin II upon the immediate and sustained increases of renal blood flow following unilateral nephrectomy. Am J Physiol Renal Physiol 2022;322:F473-85. [PMID: 35224992 DOI: 10.1152/ajprenal.00376.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Zhu X, Li K, Gao Y. Adeno-associated virus-mediated in vivo suppression of expression of EPHX2 gene modulates the activity of paraventricular nucleus neurons in spontaneously hypertensive rats. Biochem Biophys Res Commun 2022;606:121-7. [PMID: 35344709 DOI: 10.1016/j.bbrc.2022.03.084] [Reference Citation Analysis]
|
3 |
Baranowska I, Gawrys O, Walkowska A, Olszynski KH, Červenka L, Falck JR, Adebesin AM, Imig JD, Kompanowska-Jezierska E. Epoxyeicosatrienoic Acid Analog and 20-HETE Antagonist Combination Prevent Hypertension Development in Spontaneously Hypertensive Rats. Front Pharmacol 2021;12:798642. [PMID: 35111064 DOI: 10.3389/fphar.2021.798642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Imig JD. Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury. Advances in Pharmacology 2022. [DOI: 10.1016/bs.apha.2022.02.004] [Reference Citation Analysis]
|
5 |
Kala P, Miklovič M, Jíchová Š, Škaroupková P, Vaňourková Z, Maxová H, Gawrys O, Kompanowska-Jezierska E, Sadowski J, Imig JD, Falck JR, Veselka J, Červenka L, Aiglová R, Vícha M, Gloger V, Táborský M. Effects of Epoxyeicosatrienoic Acid-Enhancing Therapy on the Course of Congestive Heart Failure in Angiotensin II-Dependent Rat Hypertension: From mRNA Analysis towards Functional In Vivo Evaluation. Biomedicines 2021;9:1053. [PMID: 34440257 DOI: 10.3390/biomedicines9081053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|